Atacicept (TACI-Ig) is a homodimeric fusion protein that inhibits B-cell stimulation by binding to B-lymphocyte stimulatory factors and proliferation-inducing ligands, and can be used in the study of systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, multiple sclerosis, and various B-cell malignancies.
Purity:
97.90%
CAS Number:
[845264-92-8]
Target:
Others|||TNF
* VAT and and shipping costs not included. Errors and price changes excepted